ProteinQure
Biotech company using AI and computational platforms to design novel peptide therapeutics.
About
ProteinQure is a clinical-stage biotechnology company that leverages its proprietary computational platform, ProteinStudio™, to design novel peptide therapeutics. Their platform integrates machine learning, structural biology, and atomic-level simulations to create peptide-drug conjugates for diseases like cancer. They are advancing a pipeline of internal and partnered drug discovery projects, with a focus on precision medicine and targeted drug delivery. Teams look it up for Biotech, Drug Discovery, AI-Driven Protein Design.
Frequently asked
What does ProteinQure do?
ProteinQure is a Biotech company that offers Platform. Teams look it up for Drug Discovery, AI-Driven Protein Design, Clinical Trials. It is based in Cambridge, United States and was founded in 2017. Public records show about 32 people and $16M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has ProteinQure raised?
ProteinQure has raised a total of $16M in funding. The most recent round on record is Series A.
Where is ProteinQure headquartered?
ProteinQure is headquartered in Cambridge, United States.
When was ProteinQure founded?
ProteinQure was founded in 2017.
What industry does ProteinQure operate in?
ProteinQure operates in Biotech, Drug Discovery, AI-Driven Protein Design, Clinical Trials, Peptide Therapeutics.
How many employees does ProteinQure have?
ProteinQure has approximately 32 people on record.